Ovarian cancer study halted: lab test may help match patients to targeted drug
Knowledge-focused
Terminated
This study looked at a lab test called the RAD51 assay to see if it could identify which patients with recurrent ovarian cancer would respond to the drug olaparib. The test checks for a specific DNA repair problem in tumor cells. The study was terminated early, but it aimed to fi…
Phase: PHASE2 • Sponsor: Leiden University Medical Center • Aim: Knowledge-focused
Last updated May 01, 2026 13:32 UTC